Lumos Diagnostics Holdings Ltd

LDX

Company Profile

  • Business description

    Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.

  • Contact

    2724 Loker Avenue West
    CarlsbadCA92010
    USA

    T: +1 855 586-6739

    https://www.lumosdiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

Stocks News & Analysis

stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.
stocks

Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,850.705.100.06%
CAC 408,107.9130.110.37%
DAX 4025,464.9756.330.22%
Dow JONES (US)51,828.62478.640.93%
FTSE 10010,739.4144.160.41%
HKSE24,647.55137.460.56%
NASDAQ27,068.72129.340.48%
Nikkei 22565,877.62486.59-0.73%
NZX 50 Index13,830.6819.570.14%
S&P 5007,743.4139.280.51%
S&P/ASX 2008,679.7014.700.17%
SSE Composite Index3,823.6264.75-1.67%

Market Movers